相关实验视频

Updated: Apr 14, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

人工智能和多omics提名TAZ作为帕金森病患者的失眠相关的诊断和可用药的目标

¹Beijing Chaoyang Gaobeidian Community Health Service Center, Beijing, China.

Frontiers in aging neuroscience

|February 20, 2026

概括

失眠是一种常见的帕金森病 (PD) 并发症. 我们的研究确定TAZ是PD病变的一个关键因素,也是潜在的治疗目标,为早期诊断和治疗提供了新的途径.

科学领域:

神经科学是一个神经科学.
基因组学就是基因组学.
计算生物学计算生物学

背景情况:

失眠是帕金森病 (PD) 的普遍非运动性症状,通常在运动症状表现之前出现.
了解PD相关失眠的分子基础对于早期的PD诊断和新的治疗策略至关重要.

研究的目的:

为了研究帕金森病中失眠的分子机制.
确定PD的潜在诊断标记物和治疗点.
探索TAZ在PD病变发生中的作用及其作为药物标的潜力.

主要方法:

对人类PD黑色物质 (SN) 大量测量数据集 (GSE20141,GSE7621,GSE20164,GSE20163,GSE20333) 和与失眠相关的基因列表的综合分析.
利用差异基因表达分析 (limma) 和权重基因共同表达网络分析 (WGCNA).
采用人工智能 (AI) 驱动的框架和分子对接来识别治疗剂,通过q-RT-PCR验证.

主要成果:

TAZ (WWTR1) 表达与PD病变发生过程中失眠相关的诊断标志物增加有关,主要是在神经元内.
TAZ证明了PD诊断的显著预测性能.
BRD-K97481123被确定为一种潜在的治疗剂,用于针对TAZ治疗PD.

结论:

该研究通过综合人工智能和多omics方法阐明了帕金森病发病的TAZ机制.
作为预测生物标志物和帕金森病患者的可药物标,TAZ具有显著的潜力.
这项研究为改善PD的早期诊断和向治疗铺平了道路.

关键词:

帕金森病是帕金森氏症的一种疾病.在TAZTAZ中,我们可以看到.人工智能的人工智能是人工智能.失眠是因为失眠.多种主题的多种主题.预测模型是一个预测模型.

更多相关视频

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System

Published on: October 20, 2023

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

相关概念视频

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Management of Insomnia

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...